FDA will not subject device data systems to premarket approval

02/14/2011 | Health Data Management

The FDA is set to unveil today the final rule that would exempt medical device data systems from premarket approval by reclassifying such devices from the Class III category to Class I. In its final rule, the agency discussed the functions of an MDDS and stated the differences between an MDDS and a patient monitoring system.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA